Market Overview

Stoke Therapeutics, Inc. (STOK)

47.40 +1.25 (2.70%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/13/20Canaccord GenuityMaintainsBuy53.0
11/13/20Credit SuisseMaintainsOutperform49.0
10/23/20Cantor FitzgeraldInitiates Coverage OnOverweight49.0
9/29/20NeedhamInitiates Coverage OnBuy42.0
12/18/19WedbushInitiates Coverage OnOutperform31.0
12/03/19JP MorganMaintainsOverweight33.0
11/12/19BTIGInitiates Coverage OnNeutral46.0
10/25/19H.C. WainwrightInitiates Coverage OnBuy
7/15/19JP MorganInitiates Coverage OnOverweight34.0
7/15/19Cowen & Co.Initiates Coverage OnOutperform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter